On March 20, 2024, Nicholas Donoghoe, the Executive Vice President, Chief Business/Strategy Officer of AbbVie Inc (NYSE:ABBV), sold 21,082 shares of the company. The transaction was filed with the SEC and can be found in the following SEC Filing. According to the data provided, the insider has been active in the market over the past year, selling a total of 23,994 shares and making no purchases.